PreveCeutical Medical (PRVCF) Stock Chart & Stock Price History $0.03 +0.00 (+1.54%) As of 09:33 AM Eastern Add Compare Share Share Chart Stock AnalysisChartHeadlinesShort InterestBuy This Stock PreveCeutical Medical Stock Price Performance The PreveCeutical Medical (PRVCF) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 81.38%, with a year-to-date return of 42.93%. In the past month, the stock has decreased 17.81%, reflecting recent market activity. As of the latest close, PreveCeutical Medical traded at $0.03 with a market cap of $14.78 million and volume of 66,918 shares. Five years ago, the stock traded at $0.04, representing a 35.06% decrease over that period. At the time, it had a market cap of $18.25 million and a volume of 1.89 million shares. Receive PRVCF Stock News and Ratings via EmailSign-up to receive the latest news and ratings for PreveCeutical Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+5.62%1 Month Performance-17.81%3 Month Performance+97.74%Year-To-Date Performance+42.93%1 Year Performance+81.38%5 Year Performance-35.06% PRVCF Stock Chart for Monday, July, 7, 2025 PRVCF Chart by TradingView PreveCeutical Medical Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/04/2025$0.03$0.03$0.03$0.0266,918 shs$14.78 million07/03/2025$0.02$0.03+4.02%$0.03$0.0266,918 shs$14.78 million07/02/2025$0.02$0.02$0.03$0.02150,388 shs$14.21 million07/01/2025$0.03$0.02-1.97%$0.03$0.02150,388 shs$14.21 million06/30/2025$0.03$0.03+0.79%$0.03$0.0332,050 shs$14.50 million06/27/2025$0.03$0.03-9.03%$0.03$0.031,593 shs$14.38 million06/26/2025$0.03$0.03+9.92%$0.03$0.0332,736 shs$15.81 million06/25/2025$0.03$0.03+0.80%$0.03$0.0332,001 shs$14.38 million06/24/2025$0.03$0.03-8.09%$0.03$0.0337,173 shs$14.27 million06/23/2025$0.03$0.03-1.09%$0.03$0.036,602 shs$15.52 million Get the Latest News and Ratings for PRVCF and Related StocksEnter your email address below to receive the latest news and analysts' ratings for PreveCeutical Medical and its competitors with MarketBeat's FREE daily newsletter. 06/20/2025$0.03$0.03+10.00%$0.03$0.0333,401 shs$15.69 million06/19/2025$0.03$0.03$0.03$0.0350,000 shs$14.27 million06/18/2025$0.03$0.03-1.96%$0.03$0.0350,000 shs$14.27 million06/17/2025$0.03$0.03-0.39%$0.03$0.0325,500 shs$14.37 million06/16/2025$0.03$0.03-4.48%$0.03$0.037,410 shs$14.42 million06/13/2025$0.03$0.03$0.03$0.03500 shs$15.10 million06/12/2025$0.03$0.03+7.20%$0.03$0.03500 shs$15.10 million06/11/2025$0.02$0.03+3.73%$0.03$0.0240,700 shs$14.08 million06/10/2025$0.03$0.02-8.71%$0.03$0.0226,637 shs$13.58 million06/09/2025$0.03$0.03-17.50%$0.03$0.02145,350 shs$14.87 million06/06/2025$0.03$0.03+0.63%$0.03$0.0332,649 shs$18.03 million Related Companies Metagenomi Stock Price Chart PMV Pharmaceuticals Stock Price Chart Avalo Therapeutics Stock Price Chart Verrica Pharmaceuticals Stock Price Chart Century Therapeutics Stock Price Chart Prelude Therapeutics Stock Price Chart Mural Oncology Stock Price Chart Telomir Pharmaceuticals Stock Price Chart Cumberland Pharmaceuticals Stock Price Chart BioNxt Solutions Stock Price Chart Receive PRVCF Stock News and Ratings via EmailSign-up to receive the latest news and ratings for PreveCeutical Medical and its competitors with MarketBeat's FREE daily newsletter. This page (OTCMKTS:PRVCF) was last updated on 7/7/2025 by MarketBeat.com Staff From Our PartnersPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PreveCeutical Medical Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share PreveCeutical Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
